Italia markets open in 4 hours 40 minutes

TEVA Jul 2024 16.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,8500+0,1700 (+25,00%)
In data: 11:46AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,6800
Aperto0,8500
Denaro0,8400
Domanda1,0900
Prezzo d'esercizio16,00
Scadenza2024-07-26
Min-Max giorno0,8500 - 0,8500
Contratto - Min-MaxN/D
Volume10
Open Interest300
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.